⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9045726 | 0.62 | — | — | |
| SCHEMBL13721028 | 0.59 | — | — | |
| SCHEMBL1550826 | 0.59 | — | — | |
| SCHEMBL9966682 | 0.59 | — | — | |
| SCHEMBL1364578 | 0.59 | — | — | |
| SCHEMBL2048788 | 0.58 | — | — | |
| SCHEMBL2045252 | 0.58 | — | — | |
| SCHEMBL24514891 | 0.57 | — | — | |
| SCHEMBL10524285 | 0.57 | — | — | |
| SCHEMBL25497611 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108473502-A | 4, 6-dihydropyrrolo [3,4-C ] pyrazole-5 (1H) -carbonitrile derivatives for the treatment of cancer | 特殊治疗有限公司 | 2018-08-31 | — | — | CN | claimed |
| CN-103951601-B | The synthetic method of 2-acetyl group-1-pyrrolin | 华南农业大学 | 2017-01-04 | — | — | CN | claimed |
| CN-103951601-A | Synthesis method of 2-acetyl-1-pyrroline | UNIV SOUTH CHINA AGRICULT | 2014-07-30 | — | — | CN | claimed |
| CN-118452438-A | Gorgeous leaf extract and its preparation method and use | 芜湖智金然生物科技有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-114072395-A | Heterocyclic compounds and their use for treating helminth infections and diseases | 新基公司 | 2022-02-18 | — | — | CN | disclosed |
| CN-108003160-B | Method for synthesizing [ a ] -cyclized indole derivative | 南京理工大学 | 2020-05-19 | — | — | CN | disclosed |
| CN-108473502-A | 4, 6-dihydropyrrolo [3,4-C ] pyrazole-5 (1H) -carbonitrile derivatives for the treatment of cancer | 特殊治疗有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-103951601-B | The synthetic method of 2-acetyl group-1-pyrrolin | 华南农业大学 | 2017-01-04 | — | — | CN | disclosed |
| US-8980322-B2 | Controlled release composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-03-17 | — | — | US | disclosed |
| CN-103951601-A | Synthesis method of 2-acetyl-1-pyrroline | UNIV SOUTH CHINA AGRICULT | 2014-07-30 | — | — | CN | disclosed |
| CN-103951601-A | Synthesis method of 2-acetyl-1-pyrroline | UNIV SOUTH CHINA AGRICULT | 2014-07-30 | — | — | CN | disclosed |
| US-20070072810-A1 | Agent for treating diabetes | TAKEDA PHARMACEUTICAL COMPANY, LIMITED | 2007-03-29 | — | — | US | disclosed |
| WO-2006135723-A2 | MODIFIED RELEASE 1-[(3-HYDROXY-ADAMANT-1-YLAMINO)-ACETYL]-PYRROLIDINE-2(S)-CARBONITRILE FORMULATION | NOVARTIS AG (CH) | 2006-12-21 | — | — | WO | disclosed |
| US-20060177509-A1 | Controlled release composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-08-10 | — | — | US | disclosed |
| EP-1671649-A1 | REMEDY FOR DIABETES | Takeda Pharmaceutical Company Limited (JP) | 2006-06-21 | — | — | EP | disclosed |
| US-20060039974-A1 | Sustained release preparation | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-02-23 | — | — | US | disclosed |
| EP-1607088-A1 | CONTROLLED RELEASE COMPOSITION | Takeda Pharmaceutical Company Limited (JP) | 2005-12-21 | — | — | EP | disclosed |
| EP-1537880-A1 | SUSTAINED RELEASE PREPARATION | Takeda Pharmaceutical Company Limited (JP) | 2005-06-08 | — | — | EP | disclosed |
| EP-1227883-A1 | CATALYST FOR ASYMMETRIC TRANSFER HYDROGENATION | DSM N.V. (NL) | 2002-08-07 | — | — | EP | disclosed |
| WO-2001023088-A1 | CATALYST FOR ASYMMETRIC TRANSFER HYDROGENATION | DSM N.V. (NL) | 2001-04-05 | — | — | WO | disclosed |